Total Payments
$8,220
2024 Payments
$1,409
Companies
50
Transactions
346
Medicare Patients
13,795
Medicare Billing
$948,303
Payment Breakdown by Category
Food & Beverage$7,671 (93.3%)
Education$287.12 (3.5%)
Travel$250.52 (3.0%)
Gifts$12.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,671 | 338 | 93.3% |
| Education | $287.12 | 6 | 3.5% |
| Travel and Lodging | $250.52 | 1 | 3.0% |
| Gift | $12.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,148 | 54 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $738.49 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $676.95 | 38 | $0 (2024) |
| ABBVIE INC. | $674.88 | 30 | $0 (2024) |
| NeoTract Inc. | $664.60 | 11 | $0 (2020) |
| PFIZER INC. | $654.94 | 15 | $0 (2024) |
| Rochester Medical Corporation | $427.52 | 11 | $0 (2022) |
| Ferring Pharmaceuticals Inc. | $310.53 | 16 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $232.13 | 12 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $201.20 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,409 | 49 | Astellas Pharma US Inc ($218.58) |
| 2023 | $901.61 | 33 | Endo Pharmaceuticals Inc. ($172.22) |
| 2022 | $795.66 | 41 | Astellas Pharma US Inc ($204.16) |
| 2021 | $1,114 | 50 | Rochester Medical Corporation ($397.88) |
| 2020 | $624.27 | 25 | Janssen Biotech, Inc. ($161.21) |
| 2019 | $1,388 | 50 | NeoTract Inc. ($410.49) |
| 2018 | $994.09 | 50 | Janssen Scientific Affairs, LLC ($171.62) |
| 2017 | $994.09 | 48 | NeoTract Inc. ($206.86) |
All Payment Transactions
346 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $85.31 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/23/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $16.96 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: UROLOGY | ||||||
| 10/14/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $41.19 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Medical Device Business Services, Inc. | HEALIX KNOTLESS PEEK (Device) | Food and Beverage | In-kind items and services | $47.01 | General |
| Category: Sports Surgical | ||||||
| 10/08/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Immunotherapy | ||||||
| 10/01/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: rezum_URO | ||||||
| 09/16/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: UROLOGY | ||||||
| 09/12/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Diagnostic Imaging | ||||||
| 09/11/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: rezum_URO | ||||||
| 09/09/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $26.48 | General |
| 08/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Oncology | ||||||
| 08/14/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Oncology | ||||||
| 08/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/05/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 3,718 | 5,840 | $716,261 | $258,955 |
| 2022 | 31 | 3,731 | 5,883 | $717,794 | $251,663 |
| 2021 | 31 | 3,521 | 5,547 | $711,021 | $242,132 |
| 2020 | 28 | 2,825 | 4,596 | $618,577 | $195,553 |
Total Patients
13,795
Total Services
21,866
Medicare Billing
$948,303
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 623 | 1,105 | $193,375 | $108,046 | 55.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 188 | 188 | $45,120 | $23,902 | 53.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 94 | 114 | $57,000 | $21,410 | 37.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 15 | 99 | $79,200 | $13,513 | 17.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 90 | $18,000 | $12,702 | 70.6% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2023 | 13 | 16 | $32,000 | $10,397 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 137 | $17,125 | $9,525 | 55.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 56 | 59 | $17,700 | $8,132 | 45.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 584 | 954 | $95,400 | $8,093 | 8.5% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $30,000 | $7,052 | 23.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 56 | 56 | $13,720 | $5,983 | 43.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 44 | 64 | $9,600 | $4,241 | 44.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 737 | 1,500 | $25,500 | $3,276 | 12.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 136 | 180 | $12,240 | $3,244 | 26.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $5,100 | $3,129 | 61.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $6,000 | $2,963 | 49.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 206 | 256 | $2,816 | $2,150 | 76.4% |
| 87088 | Bacterial urine culture | Office | 2023 | 184 | 238 | $8,330 | $1,887 | 22.7% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 184 | 238 | $8,330 | $1,883 | 22.6% |
| 87184 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | Office | 2023 | 184 | 238 | $9,520 | $1,745 | 18.3% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 18 | 19 | $5,700 | $1,211 | 21.2% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 19 | 20 | $5,000 | $1,001 | 20.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 16 | 19 | $3,800 | $975.27 | 25.7% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 34 | $2,720 | $836.40 | 30.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 27 | 56 | $1,960 | $639.65 | 32.6% |
About Dr. David Weinstein, M.D
Dr. David Weinstein, M.D is a Urology healthcare provider based in Palm Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093765927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Weinstein, M.D has received a total of $8,220 in payments from pharmaceutical and medical device companies, with $1,409 received in 2024. These payments were reported across 346 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($7,671).
As a Medicare-enrolled provider, Weinstein has provided services to 13,795 Medicare beneficiaries, totaling 21,866 services with total Medicare billing of $948,303. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Palm Springs, FL
- Active Since 05/11/2006
- Last Updated 07/24/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1093765927
Products in Payments
- XTANDI (Drug) $1,247
- XIAFLEX (Biological) $664.83
- UroLift (Device) $457.74
- ERLEADA (Drug) $426.05
- Erleada (Drug) $385.31
- Xtandi (Drug) $350.73
- LUPRON DEPOT (Drug) $335.69
- ELIGARD (Drug) $304.64
- BOTOX (Biological) $208.32
- Urolift - UL400 (Device) $206.86
- FIRMAGON (Drug) $201.54
- AQUABEAM ROBOTIC SYSTEM (Device) $166.44
- Lupron Depot (Drug) $163.77
- PROVENGE (Drug) $158.36
- PROLARIS (Device) $154.35
- JELMYTO (Drug) $146.37
- Myrbetriq (Drug) $137.61
- AVEED (Biological) $132.89
- Nubeqa (Drug) $129.02
- Optilume BPH Drug Coated Balloon Catheter (Device) $120.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.